IMMUNOGEN (NASDAQ:IMGN)
8.15
0.18 (2.16%)
| IMMUNOGEN (NASDAQ:IMGN) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $8.33 | 52 Week High | $10.13 | ||
| Open | $8.07 | 52 Week Low | $3.31 | ||
| Day High | $8.28 | P/E | N/A | ||
| Day Low | $8.00 | EPS | $-0.67 | ||
| Volume | 244,054 | ||||
| More IMGN Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| IDIX | 2 | MHK | 2 |
| CSA | 2 | BEZ | 2 |
| CEC | 2 | HTZ | 2 |
| LVS | 2 | NVTL | 2 |
| PWAV | 2 | SXE | 2 |
| AXTI | 2 | BOOM | 2 |
Entities who have mentioned IMGN
- Morgan Stanley | View Related Stories »
- UBS | View Related Stories »
- Carl Icahn | View Related Stories »
- Stock Buyback | View Related Stories »
- Morgan Joseph | View Related Stories »
- Merriman Curhan Ford | View Related Stories »
- Deutsche Bank | View Related Stories »
- After-Hours Movers | View Related Stories »
- Scopia Capital | View Related Stories »
- Credit Suisse | View Related Stories »
- Goldman Sachs | View Related Stories »
- 13G | View Related Stories »
- Banc of America | View Related Stories »
- Brean Murray Carret & Co. | View Related Stories »
- Morningstar, Inc. | View Related Stories »
- Trading Radar | View Related Stories »
- David Moenning | View Related Stories »
- Dividend | View Related Stories »
- Robert W Baird | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- Lazard | View Related Stories »
- Fidelity Investments | View Related Stories »
- Jefferies & Co | View Related Stories »
- Wedbush Morgan | View Related Stories »
- Broadpoint Capital | View Related Stories »
View All Major News StreetInsider.com Major News for IMGN
- ImmunoGen (IMGN) Misses Q3 EPS by 2c; CFO Comments on Outlook
- Immunogen Inc. (IMGN) Posts Q1 Loss of $0.22; Reaffirms Guidance
- ImmunoGen (IMGN) Misses Q2 View
View All ReportsStreetInsider.com Reports on IMGN
- ImmunoGen (IMGN) To License TAP Technology to Amgen Inc.
- ImmunoGen (IMGN) volatility elevated into data presentations
- ImmunoGen (IMGN) to Make Several Poster Presentations as AACR-NCI-EORTC Conference
- After-Hours Movers 10/29: AXTI, ISSI, APKT, GNW, CEC, CSA, LVS Higher; IDIX, NVTL, TSRA, CRDC Lower
- ImmunoGen (IMGN) Misses Q3 EPS by 2c; CFO Comments on Outlook
View All Press ReleasesCompany Press Releases on IMGN
- ImmunoGen, Inc. Announces Clinical Data Presentations on Three TAP Compounds at Upcoming ASH Annual Meeting and Exposition
- ImmunoGen, Inc. Announces Second License Taken by Amgen for Right to Use the Company's TAP Technology
- ImmunoGen, Inc. Announces Encouraging Clinical Data with Its IMGN901 Compound in the Treatment of Merkel Cell Carcinoma
- Trading Overview for Poniard Pharmaceuticals Inc. Issued by Beacon Equity
- ImmunoGen, Inc. Announces Election of Howard Pien to its Board of Directors and Other Results from its Annual Meeting of Shareholders
StreetInsider Reports on IMGN by Category
View All BlogsBlogs on IMGN
- 37 Breakout Stocks on Big Volume, November 16, 2009
- Cramer's Stop Trading! Why Is Boeing Flying? (11/16/09)
- Cramer's Mad Money - Distressed Tessera (11/4/09)
- Incyte: Life After Debt (Part I)
- Three Life Science Companies Line Up for IPOs
View All FilingsSEC Filings on IMGN
- Form 4 IMMUNOGEN INC For: Nov 24 Filed by: LAMBERT JOHN
- Form 4 IMMUNOGEN INC For: Nov 19 Filed by: SAYARE MITCHEL
- Form 4 IMMUNOGEN INC For: Nov 18 Filed by: LAMBERT JOHN
- Form 4 IMMUNOGEN INC For: Nov 11 Filed by: PIEN HOWARD H
- Form 4 IMMUNOGEN INC For: Nov 11 Filed by: MCCLUSKI STEPHEN C
Comments on IMGN
No comments are currently available.
